Difference between revisions of "Mixed path"
m (→Hard in soft) |
m |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 17: | Line 17: | ||
* Integration of [[crystolecules]] (possibly produced in vacuum) into solution phase systems | * Integration of [[crystolecules]] (possibly produced in vacuum) into solution phase systems | ||
| − | == Soft in hard == | + | === Combining strengths & compensating for weaknesses=== |
| + | |||
| + | This option may be especially likely as it <br> | ||
| + | combines the different pathway approaches in a way that <br> | ||
| + | combines their strengths and compensates for their weaknesses. <br> | ||
| + | |||
| + | '''Combining strengths:''' <br> | ||
| + | – [[Incremental path]]s strength at [[System complexity scaling with self-assembly|scaling to larger system complexities '''(incremental)''']]. <br> | ||
| + | – [[Direct path]]s strength at [[introduction of total positional control]] towards [[positional atomic precision]]. <br> | ||
| + | |||
| + | '''Compensating for weaknesses:''' <br> | ||
| + | – [[Incremental path]]s challenge at [[introduction of total positional control]] towards [[positional atomic precision]]<br> | ||
| + | – [[Direct path]]s challenge at [[Creating System complexity scaling of positional assembly|scaling to larger system complexities '''(direct)''']]. <br> | ||
| + | |||
| + | == Soft in hard – foldamers in crystolecule systems == | ||
* Integration of self assembled [[foldamer]] things into crystolecular systems. | * Integration of self assembled [[foldamer]] things into crystolecular systems. | ||
| Line 29: | Line 43: | ||
* [[Incremental path]] | * [[Incremental path]] | ||
* [[Pathways]] | * [[Pathways]] | ||
| + | ---- | ||
| + | * '''[[Tether assisted assembly]]''' | ||
Latest revision as of 13:10, 19 November 2024
This "mixed path" is about a scenario wherein the incremental path and the direct path eventually at some point intermingle
thereby "cross-pollinating" which then helps along accelerating on the pathway to advanced productive nanosystems.
Contents
Mixed technology along the pathway, not necessarily mixed in the target technology
Note that taking this pathway does not mean that all far term target systems will be hybrid.
Taking this pathway rather means that there will be more options for bio-compatible operation in advanced systems (nanomedicine).
High performance systems (like e.g. in rocket engines or so) will still need to avoid all thermally fragile components.
Meaning likely no foldamers but only crystolecules. See: Consistent design for external limiting factors
Hard in soft – crystolecules in foldamer systems
- Integration of solution phase mechanosynthesis in foldamer systems
- Integration of crystolecules (possibly produced in vacuum) into solution phase systems
Combining strengths & compensating for weaknesses
This option may be especially likely as it
combines the different pathway approaches in a way that
combines their strengths and compensates for their weaknesses.
Combining strengths:
– Incremental paths strength at scaling to larger system complexities (incremental).
– Direct paths strength at introduction of total positional control towards positional atomic precision.
Compensating for weaknesses:
– Incremental paths challenge at introduction of total positional control towards positional atomic precision
– Direct paths challenge at scaling to larger system complexities (direct).
Soft in hard – foldamers in crystolecule systems
- Integration of self assembled foldamer things into crystolecular systems.
